Adjuvant therapy
HR+ HER2- Early Breast Cancer (EBC) Patients ≥70 with High Risk 70-gene Signature Benefit from (Neo)adjuvant Chemotherapy (CT): Real World FLEX Study
Publication: SABCS 2025, Presentation ID: PS3-08-17 Authors: Mahtani et Read More
Adjuvant therapy
Publication: SABCS 2025, Presentation ID: PS3-08-17 Authors: Mahtani et Read More
Publication: SABCS 2025, Presentation ID: PS5-04-19 Authors: Cobain et Read More
Publication: SABCS 2025, Presentation ID: PS2-07-03 Authors: O’Shaugnessy et Read More
Publication: JNCI Cancer Spectrum, 2025, 9(5), pkaf092 Authors: Yael Read More
Publication: JNCI Cancer Spectrum, August 2025 Authors: Brufsky et Read More
Publication: ASCO® 2025 Authors: Reshma Mahtani, Ana Sandoval-Leon, Anna Read More
Publication: European Journal of Cancer 217 (2025) 115222 Authors: Read More
Source: San Antonio Breast Cancer Symposium® Authors: Adam Brufsky*, Read More
Source: San Antonio Breast Cancer Symposium® Authors: Adam Brufsky, VK Read More
Title: 70‑Gene signature‑guided adjuvant systemic treatment adjustments in early‑stage Read More